In FD patients with potential cardiac variants, the association between higher levels of CXCL10 and lower CRAE was stronger, with a significant interaction observed between CXCL10 and cardiac variants (pinteraction = 0.048) (Fig. 6a). Here, CXCL10 is linked to Fabry disease.